Shinomiya N, Minari J, Yoshizawa G, Dando M, Shang L
Front Bioeng Biotechnol. 2022; 10:966586.
PMID: 36091454
PMC: 9458934.
DOI: 10.3389/fbioe.2022.966586.
Ackerman E, Weaver J, Shoemaker J
Viruses. 2022; 14(5).
PMID: 35632648
PMC: 9147528.
DOI: 10.3390/v14050906.
Hurlbut J
Big Data Soc. 2020; 4(2):2053951717742417.
PMID: 32431852
PMC: 7221289.
DOI: 10.1177/2053951717742417.
Arima A, Tsutsui M, Harlisa I, Yoshida T, Tanaka M, Yokota K
Sci Rep. 2018; 8(1):16305.
PMID: 30390013
PMC: 6214978.
DOI: 10.1038/s41598-018-34665-4.
Wu D, Chaiyakunapruk N, Pratoomsoot C, Lee K, Chong H, Nelson R
Epidemiol Infect. 2018; 146(4):496-507.
PMID: 29446343
PMC: 9134563.
DOI: 10.1017/S0950268818000158.
Consortia's critical role in developing medical countermeasures for re-emerging viral infections: a USA perspective.
Everts M, Suto M, Painter G, Whitley R
Future Virol. 2016; 11(3):187-195.
PMID: 27325914
PMC: 4912138.
DOI: 10.2217/fvl-2015-0011.
Intranasal Immunization of Mice to Avoid Interference of Maternal Antibody against H5N1 Infection.
Zhang F, Peng B, Chang H, Zhang R, Lu F, Wang F
PLoS One. 2016; 11(6):e0157041.
PMID: 27280297
PMC: 4900595.
DOI: 10.1371/journal.pone.0157041.
Characterization of Receptor Binding Profiles of Influenza A Viruses Using An Ellipsometry-Based Label-Free Glycan Microarray Assay Platform.
Fei Y, Sun Y, Li Y, Yu H, Lau K, Landry J
Biomolecules. 2015; 5(3):1480-98.
PMID: 26193329
PMC: 4598760.
DOI: 10.3390/biom5031480.
Reply to "Studies on influenza virus transmission between ferrets: the public health risks revisited".
Lipsitch M, Inglesby T
mBio. 2015; 6(1).
PMID: 25616376
PMC: 4323416.
DOI: 10.1128/mBio.00041-15.
One-health approach as counter-measure against "autoimmune" responses in biosecurity.
Mutsaers I
Soc Sci Med. 2014; 129:123-30.
PMID: 25446776
PMC: 7131669.
DOI: 10.1016/j.socscimed.2014.09.042.
Why has Not There been More Research of Concern?.
Rappert B
Front Public Health. 2014; 2:74.
PMID: 25101254
PMC: 4106452.
DOI: 10.3389/fpubh.2014.00074.
Evidence of selection pressures of neuraminidase gene (NA) of influenza A virus subtype H5N1 on different hosts in Guangxi Province of China.
Chen Y, Chen Y
Saudi J Biol Sci. 2014; 21(2):179-83.
PMID: 24600312
PMC: 3942850.
DOI: 10.1016/j.sjbs.2013.09.009.
Ten years on: generating innovative responses to avian influenza.
Forster P
Ecohealth. 2013; 11(1):15-21.
PMID: 24337506
PMC: 7087817.
DOI: 10.1007/s10393-013-0887-6.
Glial-mediated inflammation underlying parkinsonism.
Barcia C
Scientifica (Cairo). 2013; 2013:357805.
PMID: 24278772
PMC: 3820356.
DOI: 10.1155/2013/357805.
Engaging the normative question in the H5N1 avian influenza mutation experiments.
Swazo N
Philos Ethics Humanit Med. 2013; 8:12.
PMID: 24006905
PMC: 3766690.
DOI: 10.1186/1747-5341-8-12.
What we are watching--five top global infectious disease threats, 2012: a perspective from CDC's Global Disease Detection Operations Center.
Christian K, Ijaz K, Dowell S, Chow C, Chitale R, Bresee J
Emerg Health Threats J. 2013; 6:20632.
PMID: 23827387
PMC: 3701798.
DOI: 10.3402/ehtj.v6i0.20632.
Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect.
Ledgerwood J, Zephir K, Hu Z, Wei C, Chang L, Enama M
J Infect Dis. 2013; 208(3):418-22.
PMID: 23633407
PMC: 3699006.
DOI: 10.1093/infdis/jit180.
The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat.
Fedson D, Opal S
Hum Vaccin Immunother. 2013; 9(5):977-86.
PMID: 23391967
PMC: 3899166.
DOI: 10.4161/hv.23869.
Quantifying pathogen surveillance using temporal genomic data.
Chan J, Rabadan R
mBio. 2013; 4(1):e00524-12.
PMID: 23362319
PMC: 3560527.
DOI: 10.1128/mBio.00524-12.
H5N1 virus: Transmission studies resume for avian flu.
Fouchier R, Garcia-Sastre A, Kawaoka Y
Nature. 2013; 493(7434):609.
PMID: 23354044
DOI: 10.1038/nature11858.
